Skip to main content
. Author manuscript; available in PMC: 2014 Apr 18.
Published in final edited form as: J Matern Fetal Neonatal Med. 2012 Aug 24;25(12):2686–2689. doi: 10.3109/14767058.2012.717128

Table II.

Perinatal outcomes for women receiving 17P, presented by randomization group. Adjusted odds ratios (aOR) are obtained from logistic regression models adjusting for GA at randomization and GA at first recorded 17P dose.

Outcome Cerclage
(n = 47)
No Cerclage
(n = 52)
OR (95% CI) aOR (95% CI)
PTB < 37 weeks 23 (49) 31 (60) 0.65 (0.29 – 1.44) 0.62 (0.27 – 1.41)
PTB < 35 weeks 14 (30) 20 (38) 0.68 (0.29 – 1.57) 0.64 (0.27 – 1.52)
PTB < 32 weeks 8 (17) 11 (21) 0.77 (0.28 – 2.10) 0.63 (0.22 – 1.81)
PTB < 28 weeks 4 (9) 8 (15) 0.51 (0.14 – 1.83) 0.46 (0.12 – 1.70)
Previable birth < 24 weeks 2 (4) 1 (2) 2.27 (0.20 – 25.8) 1.92 (0.15 – 25.3)
Perinatal death 3 (6) 2 (4) 1.67 (0.27 – 10.4) 1.44 (0.22 – 9.67)

Data presented as n (%)